Delivery Order SPE2DR25D2108-SPE2DR26F6RH6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Prevnar 20 syringes (0.5mL) under a firm fixed-price contract with a ceiling value of $31,784.24. This delivery order represents a non-set-aside, competitively awarded transaction executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 million prime vendor agreement running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Prevnar 20 syringe units (0.5ML) with a ceiling value of $38,234.60. This competitively awarded, firm fixed price delivery order is scheduled for completion by December 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the company's competitive capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Prevnar 20 syringes (0.5ML) under a firm fixed-price contract valued at $3,163.90. This is a non-set-aside competitive award with an ultimate completion date of December 8, 2025, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of PREVNAR 20 vaccine syringes (0.5mL) with a ceiling value of $1,581.94 and an ultimate completion date of November 10, 2025. This non-competitive, firm fixed-price delivery order represents a straightforward pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Prevnar 20 syringes (0.5mL) with a ceiling value of $9,802.68. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract is set to be completed by July 31, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Prevnar 20 vaccine in syringe form (0.5 mL). This is a firm fixed price delivery order with a ceiling value of $1,987.74, with an ultimate completion date of November 14, 2025. The contract includes no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Prevnar 20 syringes (0.5mL), a pneumococcal vaccine. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $4,745.82 and is scheduled for completion by December 5, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract utilizes no set-aside provisions, reflecting AmerisourceBergen's competitive...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Prevnar 20 syringes. This firm fixed-price delivery order, valued at $27,774.09, represents a competitive award with no set-aside designation and is scheduled for completion by August 28, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a $12,655.52 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Prevnar 20 syringes (0.5mL). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Prevnar 20 syringes (0.5 mL) with a ceiling value of $36,157.36. This firm fixed-price delivery order, which is expected to be completed by December 4, 2025, represents a non-competitive set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's existing indefinite...
- SPE2DR25D2108Indefinite Delivery Contract
- SPE2DR25D2108-SPE2DR26F6RH6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Prevnar 20 vaccine syringes (0.5ML) with a ceiling value of $13,424.05. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with an ultimate completion date of December 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.9 billion global pharmaceutical support vehicle that runs through December 2026 and enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The company maintains an extensive portfolio of medical product deliveries through open competition, demonstrating its capability to fulfill diverse federal medical supply requirements. This Prevnar 20 delivery order supports the Defense Health Agency and other government healthcare systems through the flexible pharmaceutical prime vendor contract framework, reflecting the company's ongoing role in supplying vaccines and specialized medical commodities to support military operations and personnel healthcare globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 12/3/25 |